Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)

HKG:6826 Revenue

Shanghai Haohai Biological Technology had revenue of 607.69M CNY in the quarter ending June 30, 2026, a decrease of -11.40%. This brings the company's total for the last twelve months to 2.32B, down -10.28% year-over-year. In the year 2025, Shanghai Haohai Biological Technology had annual revenue of 2.45B, down -8.71%. That makes Shanghai Haohai Biological Technology the 13,589th largest company in the world by revenue and 808th in Hong Kong.

• Revenue (ttm): 2.32B CNY
• Revenue Growth: -10.28%
• P/S Ratio: 2.72
• Revenue / Employee: 1.16M CNY
• Employees: 1,999
• Market Cap: 7.30B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Geography

Chart

• Mainland China 2.04B 83.3%
• Europe 155.10M 6.3%
• Other Regions and Countries 141.96M 5.8%
• United States of America (USA) 112.46M 4.6%

Fiscal year ended Dec 31, 2025 See the full HKG:6826 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.45B	-233.36M	-8.71%
Dec 31, 2024	2.68B	44.76M	1.70%
Dec 31, 2023	2.63B	531.47M	25.27%
Dec 31, 2022	2.10B	353.32M	20.19%
Dec 31, 2021	1.75B	425.69M	32.14%

Data Source: S&P Global Market Intelligence Last updated: Aug 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error